FDA NDC Directory · JSON-LD · Markdown

SINGULAIR

NDC 78206-173 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Generic namemontelukast sodium
Labeler / ManufacturerOrganon LLC
Marketing categoryNew Drug Application (innovator) · App NDA020830
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsMONTELUKAST SODIUM (5 mg/1)
Marketing started20210601
Package count1

External sources

Source: openFDA. Public-domain (CC0).